Form D · Other Health Care
Phoenix Life Sciences International Limited.
Denver, CO · CIK 0001493212
Offering snapshot reported Apr 30, 2019 · SEC filing
- Reported sold
- Yet to sell Offering amount: $40M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 30, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Apr 11, 2019 | Amendment | $879,685 | No comparison | 0 | SEC filing |
| Nov 1, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 7, 2010 | Initial | $15,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $4M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-338404
Source: Form D, filed Apr 30, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brent Millward | Director, Executive |
| Martin Henry Tindall | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3000 Lawrence Street
Denver, CO, 80205
Denver, CO, 80205